Clinical Study Cohort of Idiopathic Inflammatory Myositis
ConditionIdiopathic Inflammatory Myopathies
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorRenJi Hospital
About this trial
Idiopathic inflammatory myositis (IIM), also known as myositis, are a heterogeneous group of diseases characterized by chronic inflammation of striated muscles and skin, with different clinical manifestations, treatment responses, and prognosis. This project will build a clinical follow-up cohort for idiopathic inflammatory myositis (IIM) centered on Renji Hospital, Shanghai Jiao Tong University School of Medicine, to promote the clinical and pathogenesis of this group of diseases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age≥ 18 years old and ≤ 75 years old
Meet the 2017 EULAR/ACR classification criteria for inflammatory myopathy (IIM), the above score ≥ 5.5 points if there is no muscle biopsy, and 6.7 points ≥ if there is muscle biopsy
Cooperate with follow-up, examination and treatment and voluntarily sign the informed consent form.
Disqualifiers
None
Trial population
Aged 18-75 years and eligible for the 2017 European League Against Rheumatism/American College of Rheumatology.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
no interventions were involved
Other interventionno interventions were involved
Treatment groups
1,000 Participants
are divided into 2 treatment groupsGroup A: IMM patients with tumors1 intervention
Group B: IMM patients without tumors1 intervention
Trial outcomes
Primary outcomes
1
High Resolution Computed Tomography of Chest
High Resolution Computed Tomography of Chest will be used to assess the incidence of interstitial pneumonia.
Time frame
three months2
Cutaneous Disease Area and Severity Index
Cutaneous Disease Area and Severity Index will be used to assess the the severity of the rash.
Time frame
three months3
Forced vital capacity
t refers to the maximum amount of air that cr trying to inhale as quickly as possible.
Time frame
three months4
Manual Muscle Testing
Manual Muscle Testing will be used to assess patients with muscle weakness.
Time frame
three monthsSecondary outcomes
1
Serum creatine kinase
Serum creatine kinase will be used to assess the disease activity in idiopathic inflammatory myopathies.
Time frame
three monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: